Evidence map›Paper›PMID 28774750›Full record

ReviewExperimental neurology2018

Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

M D Bauman, C M Schumann

Abstract readReview
In one paragraph

Review in Experimental neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Evolutionarily conserved neural responses to affective touch in monkeys transcend consciousness and change with age.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Longitudinal mapping of the development of cortical thickness and surface area in rhesus macaques during the first three years.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M D BaumanThe UC Davis MIND Institute, University of California, Davis, USA; Department of Psychiatry and Behavioral Sciences, University of California, Davis, USA; California National Primate Research Center, University of California, Davis, USA. Electronic address: mdbauman@ucdavis.edu.
C M SchumannThe UC Davis MIND Institute, University of California, Davis, USA; Department of Psychiatry and Behavioral Sciences, University of California, Davis, USA.

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
UC Davis Conte Center: Neuroimmune Mechanisms of Psychiatric DisordersP50MH106438 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARTER, CAMERON S. · 2015 to 2025
$26.1M
Rodent Behavior CoreU54HD079125 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAGERMAN, RANDI J. · 2013 to 2019
$8.5M
Typical and Pathological Cellular Development of the Human AmygdalaR01MH097236 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SCHUMANN, CYNTHIA · 2011 to 2022
$3.9M
Pre-clinical evaluation of oxytocin for ASD treatment discoveryR21HD080498 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMAN, MELISSA DAWN, MACHADO, CHRISTOPHER J · 2015 to 2016
$441k
Cell-specific molecular mechanisms underlying brain pathology in ASDR21MH108909 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SCHUMANN, CYNTHIA, STAMOVA, BORYANA · 2015 to 2016
$431k
NICHD NIH HHS R21 HD080498NICHD NIH HHS U54 HD079125NIH HHS P51 OD011107NIMH NIH HHS P50 MH106438NIMH NIH HHS R01 MH097236NIMH NIH HHS R21 MH108909
6 · The paper itself

Abstract

Given the prevalence and societal impact of autism spectrum disorders (ASD), there is an urgent need to develop innovative preventative strategies and treatments to reduce the alarming number of cases and improve core symptoms for afflicted individuals. Translational efforts between clinical and preclinical research are needed to (i) identify and evaluate putative causes of ASD, (ii) determine the underlying neurobiological mechanisms, (iii) develop and test novel therapeutic approaches and (iv) ultimately translate basic research into safe and effective clinical practices. However, modeling a uniquely human brain disorder, such as ASD, will require sophisticated animal models that capitalize on unique advantages of diverse species including drosophila, zebra fish, mice, rats, and ultimately, species more closely related to humans, such as the nonhuman primate. Here we discuss the unique contributions of the rhesus monkey (Macaca mulatta) model to ongoing efforts to understand the neurobiology of the disorder, focusing on the convergence of brain and behavior outcome measures that parallel features of human ASD.

Indexed as

PrimatesAnimalsAutism Spectrum DisorderAutistic DisorderDisease Models, AnimalHumansMacaca mulattaSocial BehaviorAnimal modelAutism spectrum disorderPreclinicalRhesus monkey

Identifiers

PMID28774750
PMCPMC5810939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.